ÂÜÀòÂÒÂ×

Anna Frey currently serves as Manager of CMC at Immunic Therapeutics since March 2023. Prior to this role, Anna Frey gained experience at Leibniz-Institut für Katalyse e. V. (LIKAT) from October 2014 to July 2018 during the Bachelor and Master thesis phase, and worked as a Student Assistant at CENTOGENE from April 2014 to May 2015. Anna Frey holds a Doctorate in Natural Sciences in Organic Chemistry from Universität Rostock, earned between October 2018 and October 2022, and a Master of Science in Chemistry from the same institution, completed from October 2016 to September 2018.